Bereaved families of children who died of cancer expressed a strong desire for high-quality end-of-life care that balanced comfort with continued treatment efforts, particularly chemotherapy, ...

Teclistamab produced “clinically meaningful” responses in patients with heavily pretreated multiple myeloma who had received prior anti-BCMA treatment, according to researchers.

Giredestrant has a stronger anti-proliferative effect than anastrozole in patients with estrogen receptor-positive, HER2-negative, previously untreated early breast cancer, a new study suggests.

Slowed development of academic readiness predictive of distal academic outcomes in reading, math. (HealthDay News) — Treatment of central nervous system (CNS) tumors in early childhood is associated ...

A qualitative exploratory study sought to explore how patients with breast cancer returned to their role as wife after cancer treatment.

Researchers sought to determine whether fixed-duration therapy would still be feasible for patients with RRMM who were treated with a bispecific antibody in clinical trials and discontinued.

Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy.

In a systematic review, researchers evaluated English-language studies that measured associations between the perceived injustice of pain and physical, functional, and psychosocial outcomes in ...

Multi-targeted stool DNA tests detect significantly more advanced serrated lesions compared with other stool-based tests. While stool-based tests (SBTs) do not show a significant difference in ...

A retrospective study of patients with lymphoma identified risk factors for clinically significant CMV infection in this patient population.

The CCL17/CCL22-CCR4 axis can be used as a novel biomarker for the prognosis of B-cell acute lymphoblastic leukemia (ALL), according to a new study published in the journal Cytokine. It is already ...

Researchers say the data indicate cancer cases continued to be underdiagnosed in the second year of the pandemic.